Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/1999
10/21/1999WO1999053062A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
10/21/1999WO1999053052A2 Srebp-2-deficient cell lines
10/21/1999WO1999053047A2 Porcine adenovirus type 3 genome
10/21/1999WO1999053042A2 Biological material with increased expression of endogenous complement regulatory molecules
10/21/1999WO1999053040A2 Human nucleic acid sequences from ovarian tumour tissue
10/21/1999WO1999053021A1 Cell differentiation/proliferation and maintenance factor and uses thereof
10/21/1999WO1999053020A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae
10/21/1999WO1999052947A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
10/21/1999WO1999052929A1 Nucleic acid sequences and proteins associated with aging
10/21/1999WO1999052928A1 Transporter protein splice variants and model for immune diversity
10/21/1999WO1999052925A1 Programmed cell death and caspase-12
10/21/1999WO1999052573A1 Encapsulation devices with strand, yarn or mesh core
10/21/1999WO1999052503A2 Rna cancer vaccine and methods for its use
10/21/1999WO1999052463A1 Needleless administration of polynucleotide formulations
10/21/1999WO1999047102A3 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
10/21/1999WO1999046379A3 Human receptor proteins; related reagents and methods
10/21/1999WO1999042593A8 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
10/21/1999WO1999042577A3 Biotin-binding receptor molecules
10/21/1999WO1999042137A3 Stress promoter control of therapeutic genes in gene therapy: compositions and methods
10/21/1999WO1999038992A9 Synergism between thymidine kinase gene therapy and topoisomerase i and topoisomerase ii inhibitors
10/21/1999WO1999036553A3 Regulation of biological events using multimeric chimeric proteins
10/21/1999WO1999036530A3 Lh-receptor gene promoter for tissue-specific gene expression
10/21/1999WO1999030157A9 Neuropilins in methods for diagnosis and prognosis of cancer
10/21/1999DE19817948A1 New nucleic acid sequences expressed in uterine cancer tissues, and derived polypeptides, for treatment of uterine and endometrial cancer and identification of therapeutic agents
10/21/1999DE19817946A1 New nucleic acid sequences expressed in normal uterine tissues, and derived polypeptides, for treatment of uterine cancer and identification of therapeutic agents
10/21/1999DE19817557A1 Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe Human nucleic acid sequences from Ovartumorgewebe
10/21/1999DE19806581A1 Sequenzen eines Ih-Ionenkanals und deren Verwendung Sequences of Ih ion channel and their use
10/21/1999CA2800231A1 Porcine adenovirus type 3 genome
10/21/1999CA2718812A1 Porcine adenovirus type 3 genome
10/21/1999CA2328180A1 Needleless administration of polynucleotide formulations
10/21/1999CA2327516A1 Programmed cell death and caspase-12
10/21/1999CA2325330A1 Transferrin receptor genes of moraxella
10/21/1999CA2324870A1 Modified biological material
10/21/1999CA2323934A1 Nucleic acid sequences and proteins associated with aging
10/20/1999EP0950713A2 Recombinant adenoviral vector for gene transfer
10/20/1999EP0950709A1 Antisense oligonucleotides for the inhibition of integrin alphaV-subunit expression
10/20/1999EP0950415A1 Use of a combination of an osteoinductive protein and a dorsalizing factor for cartilage induction
10/20/1999EP0950111A1 Methods using cre-lox for production of recombinant adeno-associated viruses
10/20/1999EP0950110A1 Novel morphogen-responsive signal transducer and methods of use thereof
10/20/1999EP0950105A1 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
10/20/1999EP0950104A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
10/20/1999EP0950103A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/20/1999EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999EP0950099A1 NOVEL flt-3 RECEPTOR AGONISTS
10/20/1999EP0950098A1 Stable expression of triple helical proteins
10/20/1999EP0950060A1 Antisense inhibition of human adhesion molecules
10/20/1999CN1232509A Catalytic nucleic acid and its medical use
10/20/1999CN1232503A Tumor necrosis factor related ligand
10/20/1999CN1232501A Modified TIE-2 -receptor ligands
10/20/1999CN1232499A Human growth gene and short stature gene region
10/20/1999CN1232498A Guanine exchange factor of RHO GTPase and nucleic acid encoding it
10/20/1999CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/20/1999CN1232087A Polynucleotide molecules encoding neospora proteins
10/19/1999US5969210 Reporter gene produces a fluorescent protein, sorting insulin-producing pancreatic islet cells from non-insulin-producing pancreatic islet cells by fluorescence activated cell sorting (facs).
10/19/1999US5969125 Polynucleotideds that encode polypeptides that can be used to generate antibodies to prevent, treat, and reduce effects of disease
10/19/1999US5969120 Dna molecule with synthetically mutated retinoblastoma gene encoding a mutated protein; therapy for a tumor cell with mutation in cyclin gene; antitumor agents
10/19/1999US5969117 Modified protein kinase a-specific oligonucleotide
10/19/1999US5969105 Stem cell factor receptor agonists
10/19/1999US5968909 Method of modulating gene expression with reduced immunostimulatory response
10/19/1999US5968829 Human CNS neural stem cells
10/19/1999US5968826 Antisense inhibition of integrin α4 expression
10/19/1999US5968825 Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene
10/19/1999US5968821 Adenovirus vector containing nucleotide sequence coding polypeptide which binds and inhibits cyclin kinase; screening for agonist or antagonist to cell propagation; develop immunogen; antitumor agents; diagnostic model for disease
10/19/1999US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
10/19/1999US5968816 Dna molecule which codes for protein involved in cytokine-induced programmed cell death; diagnostic and therapeutic aid in treatment and detection of alzheimer's, parkinson's, psoriasis and cancer
10/19/1999US5968803 Human DNA topoisomerase I α
10/19/1999US5968780 Dendritic cell-derived growth factor
10/19/1999US5968777 DNA encoding seryl t-RNA synthetase
10/19/1999US5968770 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
10/19/1999US5968737 Method of identifying inhibitors of glutathione S-transferase (GST) gene expression
10/19/1999US5968734 Dna sequences that migrate to new genetic positions and the fusion products; diagnosis of carcinomas, melanomas, and sarcomas suchas ewing's sarcoma
10/19/1999US5968524 Methods and compounds for the treatment of immunologically-mediated psoriasis
10/19/1999US5968513 Administering cyclic peptide; gene therapy; autoimmune diseases; anticarcinogenic agents
10/19/1999US5968502 Genetic engineering of proteins in cells
10/17/1999CA2268457A1 Mammalian rad1 genes, polypeptides and methods of use
10/14/1999WO1999051754A1 Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof
10/14/1999WO1999051751A1 Hiv cofactor inhibitors and medicinal compositions for preventing or treating hiv-infection
10/14/1999WO1999051748A2 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999WO1999051739A1 Protein variant of the net1 locus
10/14/1999WO1999051737A1 Highly active forms of interferon regulatory factor proteins
10/14/1999WO1999051735A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy
10/14/1999WO1999051729A1 Pentaerythritol lipid derivatives
10/14/1999WO1999051727A2 Human nucleic acid sequences of normal ovary tissue
10/14/1999WO1999051629A2 New compounds for dna-transfection
10/14/1999WO1999051581A1 Novel nucleic acid transfer agents, compositions containing same and uses
10/14/1999WO1999051275A2 Mesenchymal stem cells as immunosuppressants
10/14/1999WO1999051274A1 Polyene macrolide derivatives, use for vectoring molecules
10/14/1999WO1999051269A1 Adjuvant-containing vaccines
10/14/1999WO1999051268A1 Immunomodulatory compositions of mmtv antigens and methods of using same
10/14/1999WO1999051263A2 Methods and modified cells for the treatment of cancer
10/14/1999WO1999051257A1 Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient
10/14/1999WO1999051247A1 Use of human mesenchymal stem cells to induce t-cell apoptosis
10/14/1999WO1999051206A1 Cationic lipid formulation delivering nucleic acid to peritoneal tumors
10/14/1999WO1999051188A2 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999WO1999041399A9 Methods for purified aav vector production
10/14/1999WO1999040189A3 Cdnas encoding secreted proteins
10/14/1999WO1999040188A3 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations
10/14/1999WO1999039724A9 Treatment of bony defects with osteoblast precursor cells
10/14/1999WO1999038952A3 Cells or tissues with increased protein factors and methods of making and using same
10/14/1999WO1999037660A9 Meth1 and meth2 polynucleotides and polypeptides
1 ... 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 ... 870